NTQ5082

DRUG2 trials

Sponsors

Nanjing Chia-tai Tianqing Pharmaceutical, The Third Xiangya Hospital of Central South University

Conditions

Complement-mediated Hemolytic DiseasesDrug-Drug Interaction (DDI)Healthy Volunteers

Phase 1

A Phase 1 Clinical Trial of NTQ5082 in Healthy Volunteers

Not yet recruitingNCT06560593

Nanjing Chia-tai Tianqing PharmaceuticalComplement-mediated Hemolytic Diseases

Start: 2024-08-31End: 2025-02-28Target: 82Updated: 2024-08-19

A Drug-Drug Interaction Study Between NTQ5082 Capsules and Midazolam Oral Solutio

Not yet recruitingNCT07745439

The Third Xiangya Hospital of Central South UniversityDrug-Drug Interaction (DDI), Healthy Volunteers

Start: 2026-07-30End: 2027-07-31Target: 18Updated: 2026-08-04